Jennifer Kitkowski
Payments from drug & device makers
Across 90 payments — averaging $33.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$361
- AstraZeneca$346
- Novo Nordisk$234
- GSK$233
- Incyte Corporation$223
- Daiichi Sankyo Inc.$212
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,82294%
- Education$1776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 9 | $361 |
| AstraZeneca | 14 | $346 |
| Novo Nordisk | 2 | $234 |
| GSK | 5 | $233 |
| Incyte Corporation | 4 | $223 |
| Daiichi Sankyo Inc. | 10 | $212 |
| AbbVie | 2 | $153 |
| Astellas Pharma US Inc | 2 | $149 |
| Pharmacosmos Therapeutics Inc. | 2 | $143 |
| Sobi, Inc | 6 | $128 |
| Pharmaessentia USA Corporation | 3 | $101 |
| Genmab U.S., Inc. | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Bristol Myers Squibb | 2 | $59 |
| Lilly USA, LLC | 2 | $55 |
| Eisai Inc. | 2 | $51 |
| Merck | 2 | $45 |
| Caris MPI, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Novartis | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Immunocore Limited | 1 | $28 |
| EMD Serono, Inc. | 1 | $25 |
| Geron Corporation | 1 | $23 |
| Genentech USA, Inc. | 4 | $22 |
| ADC Therapeutics America, Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,999 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 12 | $484 |
| Metformin Hcl | 32 | $289 |
| Atorvastatin Calcium | 29 | $269 |
| Levothyroxine Sodium | 18 | $176 |
| Fluticasone Propionate | 14 | $155 |
| Amlodipine Besylate | 23 | $146 |
| Ondansetron Hcl | 12 | $144 |
| Montelukast Sodium | 15 | $119 |
| Lisinopril | 22 | $97 |
| Ropinirole Hcl | 12 | $90 |
| Glipizide | 11 | $88 |
| Losartan Potassium | 11 | $53 |
| Meloxicam | 13 | $51 |
| Hydrochlorothiazide | 12 | $46 |
| Furosemide | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Other family in Allen
- Karla McHughesAllen$55K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.